FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

13 results

cellcept
(Mycophenolate Mofetil)
Genentech, Inc.
Usage: CELLCEPT (mycophenolate mofetil) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used alongside other immunosuppressive agents.
cyclosporine
(CYCLOSPORINE)
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Cyclosporine capsules (modified) are indicated for preventing organ rejection in kidney, liver, and heart transplants. They also treat severe rheumatoid arthritis inadequately responding to methotrexate and manage severe, recalcitrant plaque psoriasis in nonimmunocompromised adults who have not responded to other systemic therapies.
cyclosporine
(Cyclosporine)
Strides Pharma Science Limited
Usage: Cyclosporine capsules (modified) are indicated for the prophylaxis of organ rejection in kidney, liver, and heart transplants, treatment of severe rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who have not adequately responded to systemic therapies or cannot tolerate them.
cyclosporine
(Cyclosporine)
Teva Pharmaceuticals USA, Inc.
Usage: Cyclosporine capsules, USP MODIFIED are indicated for organ rejection prophylaxis in kidney, liver, and heart transplants, treatment of severe active rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who failed previous systemic therapies or cannot tolerate them.
gengraf
(Cyclosporine)
AbbVie Inc.
Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.
mycophenolate mofetil
(MYCOPHENOLATE MOFETIL)
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Mycophenolate mofetil (MMF) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used in combination with other immunosuppressants.
mycophenolate mofetil
(Mycophenolate Mofetil hydrochloride)
BPI Labs LLC
Usage: Mycophenolate Mofetil is indicated for preventing organ rejection in adult and pediatric patients (3 months and older) who have received allogeneic kidney, heart, or liver transplants, and is used in combination with other immunosuppressants.
mycophenolate mofetil
(Mycophenolate Mofetil)
Camber Pharmaceuticals, Inc.
Usage: Mycophenolate mofetil capsules are indicated for preventing organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressive agents.
mycophenolate mofetil
(MYCOPHENOLATE MOFETIL)
Advagen Pharma Limited
Usage: Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressants.
mycophenolate mofetil
(Mycophenolate Mofetil)
Lannett Company, Inc.
Usage: Mycophenolate mofetil (MMF) is indicated for the prevention of organ rejection in adult and pediatric recipients aged 3 months and older undergoing allogeneic kidney, heart, or liver transplants, used in conjunction with other immunosuppressants.

Medications for Heart Transplantation

cellcept

cyclosporine

cyclosporine

cyclosporine

gengraf

mycophenolate mofetil

mycophenolate mofetil

mycophenolate mofetil

mycophenolate mofetil

mycophenolate mofetil